Cutaneous Microcirculation and Diabetic Foot

Summary

Cutaneous Microcirculation and Diabetic Foot is a clinical trial^[1].

Key Facts

• Cutaneous Microcirculation and Diabetic Foot is in the country of France^[2].
• Cutaneous Microcirculation and Diabetic Foot's instance of is recorded as clinical trial^[3].
• Cutaneous Microcirculation and Diabetic Foot's start time is recorded as +2012-04-30T00:00:00Z^[4].
• Cutaneous Microcirculation and Diabetic Foot's end time is recorded as +2013-05-31T00:00:00Z^[5].
• Cutaneous Microcirculation and Diabetic Foot's sponsor is recorded as Hospices Civils de Lyon^[6].
• Cutaneous Microcirculation and Diabetic Foot's main subject is recorded as diabetic foot^[7].
• Cutaneous Microcirculation and Diabetic Foot's number of participants is recorded as {'unit': '1', 'amount': '+80'}^[8].
• Cutaneous Microcirculation and Diabetic Foot's title is recorded as Cutaneous Microcirculation and Diabetic Foot^[9].
• Cutaneous Microcirculation and Diabetic Foot's short name is recorded as M2P2^[10].
• Cutaneous Microcirculation and Diabetic Foot's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Cutaneous Microcirculation and Diabetic Foot's ClinicalTrials.gov ID is recorded as NCT01963559^[12].
• Cutaneous Microcirculation and Diabetic Foot's research intervention is recorded as prilocaine^[13].
• Cutaneous Microcirculation and Diabetic Foot's research intervention is recorded as lidocaine/prilocaine^[14].
• Cutaneous Microcirculation and Diabetic Foot's research site is recorded as Claude Bernard University Lyon 1^[15].
• Cutaneous Microcirculation and Diabetic Foot's research subject recruitment status is recorded as completed^[16].
• Cutaneous Microcirculation and Diabetic Foot's study type is recorded as interventional study^[17].